TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News

Cannabis Stocks
Canopy’s Stock-Based Acquisition at a 66% Premium: What’s in it for Investors??

Tech Stocks
3 Canadian Stocks to Buy and Hold for Next 5 Years

Cannabis Stocks
WEED Stock: Should You Buy Canopy Growth Right Now?

Energy Stocks
3 Top Canadian Stocks to Buy Under $60 in April 2021

Energy Stocks
Got $2,000? Buy These 4 Canadian Stocks for Superior Returns

Cannabis Stocks
Why Canopy Growth Stock Could Double in 2021

Dividend Stocks
TSX Stocks: 3 High-Flying Names That Crashed Around 50% Recently

Cannabis Stocks
Canopy (TSX:WEED) Stock Down 37% From its February Peak: Buy Now?

Investing
Cannabis Stocks: 2 Marijuana Stocks That Could Be Millionaire Makers

Coronavirus
3 Top Stocks to Buy Under $50 for Superior Returns

Cannabis Stocks
U.S. Legalization Nears: Here Are the Best Cannabis Stocks to Buy
